Trellis Bioscience Inc. Employee Directory

Biotechnology ResearchCalifornia, United States11-50 Employees

Trellis Bioscience Inc. is a clinical-stage biotechnology company focused on discovering and developing native human monoclonal antibodies to treat and prevent drug-resistant infectious diseases. Its approach targets conserved bacterial proteins to disrupt biofilm formation, with a specific antibody candidate, TRL1068, designed for intravenous delivery to bind a highly conserved epitope present across many clinically significant bacteria. The goal is to provide highly selective antibodies that can address infections where traditional approaches struggle, aiming to reduce the persistence and spread of biofilms and associated disease. The company is based in Redwood City, California, and operates within the biotechnology research sector, pursuing therapies that leverage the human antibody repertoire to address challenging infectious disease targets. A recent development noted is the involvement of Nodenza Inc. as an investor in Trellis Bioscience. Trellis operates as a smaller, research-focused entity within the broader biopharma landscape, differentiated by its proprietary CellSpot technology and its emphasis on native human antibodies.

Sign up for free to view info

Company overview Email format